# The ACDC Study Assessing Cognitive Deterioration in COVID-19

> **NCT05855434** · — · UNKNOWN · sponsor: **NHS Grampian** · enrollment: 30 (estimated)

## Conditions studied

- SARS-CoV-2 Infection
- Cognitive Change
- Cognitive Dysfunction

## Interventions

- **DIAGNOSTIC_TEST:** Magnetic Resonance Imaging

## Key facts

- **NCT ID:** NCT05855434
- **Lead sponsor:** NHS Grampian
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-06-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05855434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05855434, "The ACDC Study Assessing Cognitive Deterioration in COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05855434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*